Developmental Study on Fatigue in Cancer
Completed · Phase 2
Conditions studied: Neoplasms
In brief
L-carnitine is a supplement (type of vitamin) that has been suggested to be decreased in patients with cancer. We will identify patients that have terminal cancer and fatigue. The purpose of this study is to determine if L-carnitine replacement improves fatigue in cancer patients with L-carnitine deficiency.
Key facts
- Study ID
- NCT00034450
- Run by
- National Center for Complementary and Integrative Health (NCCIH)
- People needed
- 140
- Starts
- 2002-01-01
- Expected to finish
- 2004-08-01
- Last updated by the study team
- 2006-08-18
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Beth Israel Medical Center — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.